Talk:Bhumyamalaki: Difference between revisions

From Charak Samhita
Jump to navigation Jump to search
Dridhabala (talk | contribs)
No edit summary
Dridhabala (talk | contribs)
No edit summary
 
(One intermediate revision by one other user not shown)
Line 7: Line 7:
|image_alt=charak samhita
|image_alt=charak samhita
|type=article
|type=article
}}[https://en.wikipedia.org/wiki/Phyllanthus_amarus Phyllanthus amarus Schumach. & Thonn.]
}}
 
[https://en.wikipedia.org/wiki/Phyllanthus_amarus Phyllanthus amarus Schumach. & Thonn.]


{{Infobox
{{Infobox
Line 28: Line 30:
|data8  = Awaited
|data8  = Awaited
}}
}}
'''[https://en.wikipedia.org/wiki/Phyllanthus_amarus Phyllanthus amarus]''' (also known as '''Tamalaki'''; Latin: ''Phyllanthus amarus'') is a small, erect annual herb belonging to the family Phyllanthaceae. Highly revered in [[Ayurveda]], it is renowned for its hepatoprotective, diuretic (''Mutrala''), anti-inflammatory, and Pitta-pacifying (''Pittasamana'') properties.<ref name="API1" />
[[File:Bhumyamalaki.jpg|thumb|'''Bhumyamalaki (''Phyllanthus amarus'')''']]
'''[https://en.wikipedia.org/wiki/Phyllanthus_amarus Phyllanthus amarus]''' Bhumyamalaki (also known as '''Tamalaki'''; Latin: ''Phyllanthus amarus'') is a small, erect annual herb belonging to the family Phyllanthaceae. Highly revered in [[Ayurveda]], it is renowned for its hepatoprotective, diuretic (''Mutrala''), anti-inflammatory, and Pitta-pacifying (''Pitta shamana'') properties.<ref name="API" />


==English name ==
==English name ==
Carry me seed / Gale of the wind
Carry me seed / Gale of the wind
==Therapeutic Use==
Bhumyamalaki is clinically indicated in the management of:<ref name="API2" />
* ''Amlapitta'' (Gastritis / Hyperacidity)
* ''Kasa'' (Cough)
* ''Kshaya'' (Chronic debility / Wasting)
* ''Kushtha'' (Dermatological disorders / Skin diseases)
* ''Pandu'' (Anemia)
* ''Prameha'' (Urinary disorders / Diabetes mellitus)
* ''Trushna'' (Excessive thirst / Polydipsia)
* ''Mutra Roga'' (Urinary system disorders)


==Other Varieties / Other Botanical names==
==Other Varieties / Other Botanical names==
Line 50: Line 42:
* ''Phyllanthus asperulatus'' Hutch.
* ''Phyllanthus asperulatus'' Hutch.
* ''Diasperus amarus'' (Schumach. & Thonn.) Kuntze
* ''Diasperus amarus'' (Schumach. & Thonn.) Kuntze
[[File:watermarked_img_6111021256528253381.png|thumb|Habit, foliage, and abaxial fruit arrangement of Phyllanthus amarus (Bhumyamalaki)]]


== Botanical Profile & Traditional Context ==
== Botanical Profile & Traditional Context ==
Line 60: Line 50:


==Additional Synonyms in Bhavaprakasha Nighantu==
==Additional Synonyms in Bhavaprakasha Nighantu==
* ''Shiva'' &ndash; Highly potent medicine and regarded as one of the best therapeutic herbs.<ref name="Bhavaprakash1" />
* ''Shiva'' &ndash; Highly potent medicine and regarded as one of the best therapeutic herbs.<ref name="Bhavaprakash" />
* ''Tamalaki'' &ndash; A very small and tender herb.<ref name="Bhavaprakash2" />
* ''Tamalaki'' &ndash; A very small and tender herb.<ref name="Bhavaprakash" />
* ''Bahupatra'' &ndash; Characterized by numerous small leaves.<ref name="Bhavaprakash3" />
* ''Bahupatra'' &ndash; Characterized by numerous small leaves.<ref name="Bhavaprakash" />
* ''Bahuphala'' &ndash; Yields a large number of tiny fruits along the branchlets.<ref name="Bhavaprakash4" />
* ''Bahuphala'' &ndash; Yields a large number of tiny fruits along the branchlets.<ref name="Bhavaprakash" />
* ''Bahuvirya'' &ndash; Endowed with potent and multi-faceted medicinal efficacy.<ref name="Bhavaprakash5" />
* ''Bahuvirya'' &ndash; Endowed with potent and multi-faceted medicinal efficacy.<ref name="Bhavaprakash" />
 
==Therapeutic Use==
Bhumyamalaki is clinically indicated in the management of:<ref name="API" />
* ''Amlapitta'' (Gastritis / Hyperacidity)
* ''Kasa'' (Cough)
* ''Kshaya'' (Chronic debility / Wasting)
* ''Kushtha'' (Dermatological disorders / Skin diseases)
* ''Pandu'' (Anemia)
* ''Prameha'' (Urinary disorders / Diabetes mellitus)
* ''Trushna'' (Excessive thirst / Polydipsia)
* ''Mutra Roga'' (Urinary system disorders)


== Ayurvedic pharmacological properties ==
== Ayurvedic pharmacological properties ==
According to Ayurvedic pharmacodynamics, the properties (''Rasa Panchaka'') of Bhumyamalaki are summarized below:<ref name="API3" />
According to Ayurvedic pharmacodynamics, the properties (''Rasa Panchaka'') of Bhumyamalaki are summarized below:<ref name="API" />
{| class="wikitable sortable" style="text-align:left;"
{| class="wikitable sortable" style="text-align:left;"
! Sr. No. !! Pharmacological Criteria !! Properties (Ayurvedic Attributes)
! Sr. No. !! Pharmacological Criteria !! Properties (Ayurvedic Attributes)
Line 141: Line 142:


==Dose==
==Dose==
* '''Fresh Juice (''Swarasa''):''' 10 – 20 ml of the expressed juice.<ref name="API4" />
* '''Fresh Juice (''Swarasa''):''' 10 – 20 ml of the expressed juice.<ref name="API" />
* '''Powder (''Churna''):''' 3 – 6 g of the dried drug powder.<ref name="API5" />
* '''Powder (''Churna''):''' 3 – 6 g of the dried drug powder.<ref name="API" />


==Important Formulations==
==Important Formulations==
Line 224: Line 225:
== References ==
== References ==
{{Reflist|refs=
{{Reflist|refs=
<ref name="API1">{{cite book |title=The Ayurvedic Pharmacopoeia of India |year=1986 |publisher=Department of Ayush, Ministry of Health and Family Welfare, Govt. of India |volume=1 |pages=70 |edition=Part I}}</ref>
<ref name="API">{{cite book |title=The Ayurvedic Pharmacopoeia of India |year=1986 |publisher=Department of Ayush, Ministry of Health and Family Welfare, Govt. of India |volume=1 |pages=70–71 |edition=Part I}}</ref>
<ref name="API2">{{cite book |title=The Ayurvedic Pharmacopoeia of India |year=1986 |publisher=Department of Ayush, Ministry of Health and Family Welfare, Govt. of India |volume=1 |pages=70 |edition=Part I}}</ref>
<ref name="Bhavaprakash">{{cite book |last=Chunekar |first=K. C. |title=Bhavaprakash Nighantu |year=2020 |publisher=Chaukhambha Bharati Academy |pages=Guduchyadi varga, verse 277 |edition=Reprint}}</ref>
<ref name="Bhavaprakash1">{{cite book |last=Chunekar |first=K. C. |title=Bhavaprakash Nighantu |year=2020 |publisher=Chaukhambha Bharati Academy |pages=Guduchyadi varga, verse 277 |edition=Reprint}}</ref>
<ref name="Bhavaprakash2">{{cite book |last=Chunekar |first=K. C. |title=Bhavaprakash Nighantu |year=2020 |publisher=Chaukhambha Bharati Academy |pages=Guduchyadi varga, verse 277 |edition=Reprint}}</ref>
<ref name="Bhavaprakash3">{{cite book |last=Chunekar |first=K. C. |title=Bhavaprakash Nighantu |year=2020 |publisher=Chaukhambha Bharati Academy |pages=Guduchyadi varga, verse 277 |edition=Reprint}}</ref>
<ref name="Bhavaprakash4">{{cite book |last=Chunekar |first=K. C. |title=Bhavaprakash Nighantu |year=2020 |publisher=Chaukhambha Bharati Academy |pages=Guduchyadi varga, verse 277 |edition=Reprint}}</ref>
<ref name="Bhavaprakash5">{{cite book |last=Chunekar |first=K. C. |title=Bhavaprakash Nighantu |year=2020 |publisher=Chaukhambha Bharati Academy |pages=Guduchyadi varga, verse 277 |edition=Reprint}}</ref>
<ref name="API3">{{cite book |title=The Ayurvedic Pharmacopoeia of India |year=1986 |publisher=Department of Ayush, Ministry of Health and Family Welfare, Govt. of India |volume=1 |pages=70-71 |edition=Part I}}</ref>
<ref name="API4">{{cite book |title=The Ayurvedic Pharmacopoeia of India |year=1986 |publisher=Department of Ayush, Ministry of Health and Family Welfare, Govt. of India |volume=1 |pages=71 |edition=Part I}}</ref>
<ref name="API5">{{cite book |title=The Ayurvedic Pharmacopoeia of India |year=1986 |publisher=Department of Ayush, Ministry of Health and Family Welfare, Govt. of India |volume=1 |pages=71 |edition=Part I}}</ref>
<ref name="Pramyothin2007">{{cite journal |last1=Pramyothin |first1=P. |last2=Ngamtin |first2=C. |last3=Poungrickhyo |first3=S. |last4=Suttisri |first4=R. |year=2007 |title=Hepatoprotective activity of Phyllanthus amarus Schum. & Thonn. extract in ethanol-treated rats: in vitro and in vivo studies |journal=Journal of Ethnopharmacology |volume=112 |issue=3 |pages=452–458}}</ref>
<ref name="Pramyothin2007">{{cite journal |last1=Pramyothin |first1=P. |last2=Ngamtin |first2=C. |last3=Poungrickhyo |first3=S. |last4=Suttisri |first4=R. |year=2007 |title=Hepatoprotective activity of Phyllanthus amarus Schum. & Thonn. extract in ethanol-treated rats: in vitro and in vivo studies |journal=Journal of Ethnopharmacology |volume=112 |issue=3 |pages=452–458}}</ref>
<ref name="Thyagarajan1988">{{cite journal |last1=Thyagarajan |first1=S. P. |last2=Subramanian |first2=S. |last3=Thirunalasundari |first3=T. |last4=Venkateswaran |first4=P. S. |last5=Blumberg |first5=B. S. |year=1988 |title=Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus |journal=Lancet |volume=2 |issue=8614 |pages=764–766}}</ref>
<ref name="Thyagarajan1988">{{cite journal |last1=Thyagarajan |first1=S. P. |last2=Subramanian |first2=S. |last3=Thirunalasundari |first3=T. |last4=Venkateswaran |first4=P. S. |last5=Blumberg |first5=B. S. |year=1988 |title=Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus |journal=Lancet |volume=2 |issue=8614 |pages=764–766}}</ref>
Line 242: Line 235:
<ref name="Patel2011">{{cite journal |last1=Patel |first1=J. R. |last2=Tripathi |first2=P. |last3=Sharma |first3=V. |last4=Chauhan |first4=N. S. |last5=Dixit |first5=V. K. |year=2011 |title=Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review |journal=Journal of Ethnopharmacology |volume=138 |issue=2 |pages=286–313}}</ref>
<ref name="Patel2011">{{cite journal |last1=Patel |first1=J. R. |last2=Tripathi |first2=P. |last3=Sharma |first3=V. |last4=Chauhan |first4=N. S. |last5=Dixit |first5=V. K. |year=2011 |title=Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review |journal=Journal of Ethnopharmacology |volume=138 |issue=2 |pages=286–313}}</ref>
}}
}}
[[Index.php?title=Category:Database of herbs and minerals| Herbs]]
 
== External links ==
 
[https://cb.imsc.res.in/imppat/phytochemical/Phyllanthus%20amarus IMPPAT database]
[[Index.php?title=Category:Database of herbs and minerals|Herbs]]

Latest revision as of 06:25, 9 September 2026


Phyllanthus amarus Schumach. & Thonn.

Tamalaki (Bhumyamalaki)
Section/Chapter Herb database/Tamalaki
Botanical name(s) Phyllanthus amarus Schumach. & Thonn.
Family Phyllanthaceae
Availability Available
Contributors Team Dravyaguna
Year of publication 2026
Publisher Charak Samhita Research, Training and Skill Development Centre
DOI Awaited
Bhumyamalaki (Phyllanthus amarus)

Phyllanthus amarus Bhumyamalaki (also known as Tamalaki; Latin: Phyllanthus amarus) is a small, erect annual herb belonging to the family Phyllanthaceae. Highly revered in Ayurveda, it is renowned for its hepatoprotective, diuretic (Mutrala), anti-inflammatory, and Pitta-pacifying (Pitta shamana) properties.[1]

English name

Carry me seed / Gale of the wind

Other Varieties / Other Botanical names

  • Phyllanthus niruri sensu auct. non L.
  • Phyllanthus fraternus G.L.Webster
  • Phyllanthus nanus Hook.f.
  • Phyllanthus asperulatus Hutch.
  • Diasperus amarus (Schumach. & Thonn.) Kuntze

Botanical Profile & Traditional Context

In traditional medicine, Bhumyamalaki is regarded as an exceptionally potent cooling, metabolic, and liver-protective herb. It is known to mitigate morbid Pitta and Kapha doshas while cleansing Rakta dhatu (blood tissue) and Mutravaha srotas (urinary tract). Its historical indications span acute and chronic jaundiced states, burning sensations, intermittent fevers, respiratory complaints, and kidney stones.

Synonyms in Charak Samhita

Tamalaki, Bhumyamalaki

Additional Synonyms in Bhavaprakasha Nighantu

  • Shiva – Highly potent medicine and regarded as one of the best therapeutic herbs.[2]
  • Tamalaki – A very small and tender herb.[2]
  • Bahupatra – Characterized by numerous small leaves.[2]
  • Bahuphala – Yields a large number of tiny fruits along the branchlets.[2]
  • Bahuvirya – Endowed with potent and multi-faceted medicinal efficacy.[2]

Therapeutic Use

Bhumyamalaki is clinically indicated in the management of:[1]

  • Amlapitta (Gastritis / Hyperacidity)
  • Kasa (Cough)
  • Kshaya (Chronic debility / Wasting)
  • Kushtha (Dermatological disorders / Skin diseases)
  • Pandu (Anemia)
  • Prameha (Urinary disorders / Diabetes mellitus)
  • Trushna (Excessive thirst / Polydipsia)
  • Mutra Roga (Urinary system disorders)

Ayurvedic pharmacological properties

According to Ayurvedic pharmacodynamics, the properties (Rasa Panchaka) of Bhumyamalaki are summarized below:[1]

Sr. No. Pharmacological Criteria Properties (Ayurvedic Attributes)
1 Taste (Rasa) Sweet (Madhura), Bitter (Tikta), Astringent (Kashaya)
2 Potency (Veerya) Cold (Sita)
3 Post-digestion Effect (Vipaka) Sweet (Madhura)
4 Qualities (Guna) Light (Laghu), Dry (Ruksha)
5 Actions (Karma) Mutrala (diuretic), Rochana (appetite and taste enhancer), Dahanashini (reduces burning sensation), Pittasamana (pacifies Pitta dosha)

Reference in Charak Samhita and its actions

Bhumyamalaki (Tamalaki) is widely referenced across numerous clinical contexts and therapeutic formulations in the Charaka Samhita:

Sr. No. Reference in Charak Samhita Activity / Indication / Formulation
1 Cha.Sa.Sutra Sthana 4/36 Cough-relieving group (Kasahara Mahakashaya)
2 Cha.Sa.Sutra Sthana 4/37 Anti-dyspneic / respiratory-easing group (Swasahara Mahakashaya)
3 Cha.Sa.Chikitsa Sthana 1/1/63 Key ingredient of Chyavanprasha
4 Cha.Sa.Chikitsa Sthana 3/219 Ingredient of medicated ghee (Ghrita Yoga)
5 Cha.Sa.Chikitsa Sthana 3/225 Ingredient of medicated ghee (Ghrita Yoga)
6 Cha.Sa.Chikitsa Sthana 5/119 Ingredient of Trayamanadi Ghrita
7 Cha.Sa.Chikitsa Sthana 8/70 Dietary article in the management of tuberculosis / wasting (Rajayakshma)
8 Cha.Sa.Chikitsa Sthana 8/108 Ingredient of Duralabhadi Ghrita
9 Cha.Sa.Chikitsa Sthana 8/112 Ingredient of Jivantyadi Ghrita
10 Cha.Sa.Chikitsa Sthana 11/37 Ingredient of Amritaprasa Ghrita
11 Cha.Sa.Chikitsa Sthana 17/102 Ingredient of Dashamuladi Yavagu
12 Cha.Sa.Chikitsa Sthana 17/123 Ingredient of Shatyadi Churna
13 Cha.Sa.Chikitsa Sthana 17/130 Ingredient of medicated nasal formulation (Nasya)
14 Cha.Sa.Chikitsa Sthana 17/142 Ingredient of Tejovatyadi Ghrita
15 Cha.Sa.Chikitsa Sthana 18/40 Ingredient of Tryushanadi Ghrita
16 Cha.Sa.Chikitsa Sthana 18/101 Indicated in the management of Pitta-dominant cough (Pittaja Kasa)
17 Cha.Sa.Chikitsa Sthana 18/120 Indicated in the management of Kapha-dominant cough (Kaphaja Kasa)
18 Cha.Sa.Chikitsa Sthana 18/127 Ingredient of Kantakari Ghrita
19 Cha.Sa.Chikitsa Sthana 18/178 Ingredient of Padmakadi Leha
20 Cha.Sa.Chikitsa Sthana 26/87 Indicated in the management of Vata-dominant heart disease (Vataja Hridroga)
21 Cha.Sa.Chikitsa Sthana 26/170 Ingredient of Maha Mayura Ghrita
22 Cha.Sa.Chikitsa Sthana 28/159 Ingredient of Amritadi Taila
23 Cha.Sa.Chikitsa Sthana 29/58 Ingredient of Parushaka Ghrita
24 Cha.Sa.Chikitsa Sthana 29/93 Ingredient of Madhuparnyadi Taila
25 Cha.Sa.Chikitsa Sthana 29/153 Indicated in the treatment of gout / arthritis (Vatarakta)
26 Cha.Sa.Siddhi Sthana 12/19 Ingredient of Baladi Sneha Basti (unctuous enema)

Dose

  • Fresh Juice (Swarasa): 10 – 20 ml of the expressed juice.[1]
  • Powder (Churna): 3 – 6 g of the dried drug powder.[1]

Important Formulations

  • Chyavanprasha
  • Chitraka Haritaki
  • Madhuyastyadi Taila
  • Pippalyadi Ghrita
  • Shatavari Guda

Current availability

Available

  • Status: Widely distributed and cultivated as a medicinal weed throughout the tropical and subtropical plains of India.
  • Global Distribution: Indigenous and naturalized across South Asia, Southeast Asia, tropical Africa, and the Caribbean.

Current researches

Phytochemical Composition

The therapeutic potential of Phyllanthus amarus stems from a rich array of secondary metabolites extracted across the aerial and root parts:

  • Lignans: Phyllanthin, hypophyllanthin, phyltetralin, niranthin, nirtetralin, and lintetralin.
  • Hydrolyzable Tannins & Polyphenols: Geraniin, corilagin, amariin, furosin, and gallic acid derivatives.
  • Flavonoids: Quercetin, quercitrin, isoquercitrin, astragalin, and rutin.
  • Alkaloids & Terpenoids: Securinine-type alkaloids (norsecurinine, securinine), lupeol, and lupeol acetate.

Pharmacological Activities & Therapeutic Efficacy

Hepatoprotective and Membrane-Stabilizing Activity

Phyllanthus amarus is globally acknowledged for its capacity to protect the liver parenchyma from acute and chronic insults.

  • Mechanism: The principal lignans—phyllanthin and hypophyllanthin—inhibit microsomal lipid peroxidation, restore reduced glutathione (GSH) levels, and preserve membrane ATPase enzymes in damaged hepatocytes.
  • Scientific Evidence: Experimental studies show that standardized extracts markedly attenuate drug-, alcohol-, and chemical-induced increases in serum transaminases (ALT, AST), alkaline phosphatase (ALP), and direct bilirubin, promoting accelerated hepatocellular regeneration.[3]

Antiviral and Anti-Hepatitis B Activity

The herb possesses pronounced inhibitory properties against pathogenic hepatic and enveloped viruses.

  • Mechanism: Polyphenolic constituents and ellagitannins disrupt viral replication by downregulating viral mRNA transcription, inhibiting viral DNA polymerase, and blocking core antigen secretion.
  • Scientific Evidence: Seminal research by Thyagarajan and Blumberg established significant clearance of the hepatitis B virus surface antigen (HBsAg) in chronic HBV carriers. Subsequent molecular investigations have confirmed down-regulation of the HBV enhancer I/X promoter complex and inhibition of reverse transcriptase activity.[4][5]

Nephroprotective and Anti-Urolithic Effects

In agreement with its traditional Mutrala (diuretic) and urinary cleansing classification, P. amarus serves as an effective anti-stone agent.

  • Mechanism: It disrupts the aggregation and endocytosis of calcium oxalate (CaOx) crystals on tubular epithelium, alters urinary glycosaminoglycan profiles, and downregulates stone matrix crystallization promoters.
  • Scientific Evidence: Preclinical and clinical models demonstrate that administration reduces urinary oxalate, uric acid, and calcium levels, facilitating spontaneous passage and preventing recurrent micro-calculi formation.[6]

Anti-Inflammatory, Analgesic, and Immunomodulatory Actions

The herb exhibits potent anti-inflammatory effects that mitigate metabolic and inflammatory tissue destruction.

  • Mechanism: Bioactive isolates like niranthin inhibit pro-inflammatory enzymes, notably cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), while suppressing the nuclear translocation of nuclear factor-kappa B (NF-κB).
  • Scientific Evidence: In vivo assays demonstrate marked reductions in paw edema, thermal allodynia, and circulating TNF-α and IL-1β levels following oral extract administration.[7]

Anti-Diabetic and Hypolipidemic Efficacy

Corroborating the classical indication for Prameha (urinary and metabolic syndromes), the herb exerts systemic anti-diabetic and metabolic regulation.

  • Mechanism: Extracts stimulate pancreatic β-cell insulin secretion, reduce hepatic glucose output, and competitively inhibit intestinal α-amylase and α-glucosidase enzymes.
  • Scientific Evidence: Preclinical studies show that continuous administration results in significant reductions in fasting blood glucose, total cholesterol, triglycerides, and LDL levels, accompanied by improved cellular antioxidant status in pancreatic and vascular beds.[8]

Safety, Toxicity, and Dosage

  • Acute Toxicity: Phyllanthus amarus demonstrates a remarkably high margin of safety. Acute and subacute animal toxicity studies report no adverse mortality or behavioral alterations at oral doses exceeding 2,000–5,000 mg/kg body weight.[9]
  • Precautions: Due to historical emmenagogue associations at excessive concentrations, caution is advised during early pregnancy unless supervised by an experienced practitioner.
  • Standard Therapeutic Dosage:
    • Whole Plant Powder (Churna): 3–6 g daily in divided doses.
    • Fresh Plant Juice (Swarasa): 10–20 ml twice daily before meals.
    • Standardized Extract: 250–500 mg twice daily.

Summary of Therapeutic Profile

Therapeutic Applications of Phyllanthus amarus
Indication Active Biomolecules Primary Pharmacological Action
Hepatotoxicity & Hepatitis Phyllanthin, Hypophyllanthin, Corilagin Hepatic cytoprotection, DNA polymerase inhibition, GSH restoration
Renal Calculi (Urolithiasis) Ellagitannins, Alkaloids, Flavonoids Crystal anti-adherence, Diuresis, Uric acid clearance
Metabolic Syndrome / Prameha Quercetin, Astragalin, Lignans α-glucosidase inhibition, Insulin stimulation, Lipid lowering
Chronic Inflammation Niranthin, Geraniin, Rutin NF-κB inhibition, COX-2 down-regulation, Cytokine suppression

References

  1. 1.0 1.1 1.2 1.3 1.4 The Ayurvedic Pharmacopoeia of India. 1 (Part I ed.). Department of Ayush, Ministry of Health and Family Welfare, Govt. of India. 1986. pp. 70–71. 
  2. 2.0 2.1 2.2 2.3 2.4 Chunekar, K. C. (2020). Bhavaprakash Nighantu (Reprint ed.). Chaukhambha Bharati Academy. pp. Guduchyadi varga, verse 277. 
  3. Pramyothin, P.; Ngamtin, C.; Poungrickhyo, S.; Suttisri, R. (2007). "Hepatoprotective activity of Phyllanthus amarus Schum. & Thonn. extract in ethanol-treated rats: in vitro and in vivo studies". Journal of Ethnopharmacology. 112 (3): 452–458. 
  4. Thyagarajan, S. P.; Subramanian, S.; Thirunalasundari, T.; Venkateswaran, P. S.; Blumberg, B. S. (1988). "Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus". Lancet. 2 (8614): 764–766. 
  5. Lee, C. D.; Ott, M.; Thyagarajan, S. P.; Shafritz, D. A.; Burk, R. D.; Gupta, S. (1996). "Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and inhibits HBV polymerase activity". European Journal of Clinical Investigation. 26 (12): 1069–1076. 
  6. Freitas, A. M.; Schor, N.; Boim, M. A. (2002). "The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and skeletal retention of 99mTc-methylene diphosphonate". BJU International. 89 (9): 829–834. 
  7. Kassuya, C. A. L.; Silvestre, A.; Menezes-de-Lima, O.; Marotta, D. M.; Rehder, V. L. G.; Calixto, J. B. (2006). "Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus". European Journal of Pharmacology. 546 (1-3): 182–188. 
  8. Adeneye, A. A.; Amole, O. O.; Adeneye, A. K. (2006). "Hypoglycemic and hypocholesterolemic activities of the aqueous leaf and seed extract of Phyllanthus amarus in mice". Fitoterapia. 77 (7-8): 511–514. 
  9. Patel, J. R.; Tripathi, P.; Sharma, V.; Chauhan, N. S.; Dixit, V. K. (2011). "Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review". Journal of Ethnopharmacology. 138 (2): 286–313. 

External links

IMPPAT database Herbs